{"result": "\n{\n    \"title\": \"Hydrocortisone and Fludrocortisone in Septic Shock Treatment\",\n    \"summary\": \"This community focuses on the use of hydrocortisone and fludrocortisone in the treatment of septic shock, with significant involvement in various clinical trials such as the APROCCHSS and CORTICUS studies. The entities are interconnected through their roles in these trials, with hydrocortisone being a central component in managing septic shock and related conditions. The community also includes entities like Rotexmedica and Klocke Verpackungs Service, which are involved in the preparation and handling of the medication used in these studies.\",\n    \"rating\": 8.5,\n    \"rating_explanation\": \"The impact severity rating is high due to the critical role of these medications in managing life-threatening conditions like septic shock.\",\n    \"findings\": [\n        {\n            \"summary\": \"Hydrocortisone's central role in septic shock treatment\",\n            \"explanation\": \"Hydrocortisone is extensively studied and used in the context of septic shock, a severe and potentially life-threatening condition. It is administered to patients with septic shock to evaluate its impact on mortality and secondary outcomes. Clinical trials have been conducted to assess its potential to prevent or resolve septic shock, with a focus on its hemodynamic effects and the speed of resolution. While hydrocortisone is used in the treatment of septic shock with the aim of reducing mortality and improving patient survival, studies have shown mixed results regarding its effectiveness in decreasing mortality rates. Despite these mixed outcomes, hydrocortisone remains a significant component of therapeutic strategies for managing septic shock [Data: Entities (36); Relationships (122, 196, 195, 193, 204)].\"\n        },\n        {\n            \"summary\": \"Combination therapy with fludrocortisone\",\n            \"explanation\": \"Fludrocortisone is often used in combination with hydrocortisone in the treatment of septic shock, as seen in various clinical trials including the APROCCHSS trial. Despite its use, there have been instances where fludrocortisone was not administered in certain trials due to previous findings suggesting it was ineffective for some patients with septic shock. However, its combination with hydrocortisone remains a common therapeutic approach in managing this critical condition [Data: Entities (37); Relationships (123, 190, 210)].\"\n        },\n        {\n            \"summary\": \"Clinical trials and studies involving hydrocortisone\",\n            \"explanation\": \"Hydrocortisone has been a subject of numerous clinical trials and studies, such as the CORTICUS and APROCCHSS trials, which primarily evaluated its use as a treatment for septic shock. These studies have explored its efficacy in reversing septic shock more quickly and its association with lower mortality at ICU and hospital discharge. The Surviving Sepsis Campaign also includes hydrocortisone as a recommended treatment option for patients experiencing refractory septic shock [Data: Entities (36); Relationships (195, 205, 206, 207, 193)].\"\n        },\n        {\n            \"summary\": \"Impact on delirium and superinfection\",\n            \"explanation\": \"Hydrocortisone treatment has been studied to assess its impact on the development of delirium, with research indicating that it is associated with a lower risk of developing this condition. However, the use of hydrocortisone was also associated with an increased incidence of superinfection, highlighting the need for careful consideration of its benefits and risks in clinical settings [Data: Entities (400, 615); Relationships (198, 204)].\"\n        },\n        {\n            \"summary\": \"Role of supporting entities in clinical trials\",\n            \"explanation\": \"Entities such as Rotexmedica and Klocke Verpackungs Service play crucial roles in the clinical trials involving hydrocortisone. Rotexmedica prepared the hydrocortisone used in the study, while Klocke Verpackungs Service was responsible for coding and masking the hydrocortisone vials. These entities ensure the proper handling and administration of the medication, which is vital for the integrity and success of the clinical trials [Data: Entities (603, 604); Relationships (202, 203)].\"\n        }\n    ]\n}", "input": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\n36,HYDROCORTISONE,\"Hydrocortisone is a corticosteroid medication and natural hormone used in the treatment of severe sepsis, septic shock, and adrenal insufficiency. It is often combined with fludrocortisone for treating adrenal insufficiency and septic shock. In the context of the study, hydrocortisone was administered as a 50-mg intravenous bolus every 6 hours to assess its effects on inflammation, immune responses, hyperglycemia, delirium, and survival in patients with septic shock. The study involved administering hydrocortisone to 190 patients to evaluate its impact on severe sepsis or septic shock, with a specific focus on comparing its effects to a placebo. Additionally, it was administered to 344 patients who received dopamine and 326 patients who received norepinephrine. The medication was evaluated in the CORTICUS study and was prepared by Rotexmedica for use as an adjunctive therapy in patients with septic shock, with the aim of studying its effects on mortality and secondary outcomes.\",21\n37,FLUDROCORTISONE,\"Fludrocortisone is a synthetic corticosteroid and mineralocorticoid used in combination with hydrocortisone in various clinical trials, including the APROCCHSS trial and the Annane study, to treat conditions such as septic shock and adrenal insufficiency. In these studies, it was administered as a daily dose of 50 μg orally. Despite its use in these trials, fludrocortisone was previously shown to be ineffective in the context of the specific trial mentioned. It was also compared against a placebo in the study to evaluate its efficacy.\",7\n400,DELERIUM,\"DELERIUM is a condition characterized by confusion and reduced awareness. It has been studied in relation to cortisol levels and hydrocortisone treatment. In particular, delirium is assessed in ICU patients, and its frequency can be affected by hydrocortisone treatment.\",4\n644,DROTRECOGIN ALFA,\"A drug used in the APROCCHSS trial, also known as activated protein C, to treat septic shock\",2\n377,ANNANE,Researcher involved in a study that showed hydrocortisone improved survival and reversal of septic shock in patients with relative adrenal insufficiency,1\n399,CRITICAL ILLNESS–RELATED CORTICOSTEROID INSUFFICIENCY (CIRCI),\"CIRCI is a condition affecting cortisol levels in critically ill patients, impacting the development of septic shock\",1\n603,ROTEXMEDICA,Rotexmedica is the company that prepared the hydrocortisone vials used in the study,1\n604,KLOCKE VERPACKUNGS SERVICE,Klocke Verpackungs Service is responsible for coding and masking the vials of hydrocortisone and placebo centrally,1\n615,SUPERINFECTION,An increased incidence of new infections observed in the hydrocortisone group during the study,1\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,rank\n122,SEPTIC SHOCK,HYDROCORTISONE,\"Hydrocortisone is extensively studied and used in the context of septic shock, a severe and potentially life-threatening condition. It is administered to patients with septic shock to evaluate its impact on mortality and secondary outcomes. Clinical trials have been conducted to assess its potential to prevent or resolve septic shock, with a focus on its hemodynamic effects and the speed of resolution. While hydrocortisone is used in the treatment of septic shock with the aim of reducing mortality and improving patient survival, studies have shown mixed results regarding its effectiveness in decreasing mortality rates. Despite these mixed outcomes, hydrocortisone remains a significant component of therapeutic strategies for managing septic shock.\",91\n123,SEPTIC SHOCK,FLUDROCORTISONE,\"Fludrocortisone is a medication used in the treatment of septic shock, often in combination with hydrocortisone, to help reduce mortality. Despite its use, there have been instances where fludrocortisone was not administered in certain trials due to previous findings suggesting it was ineffective for some patients with septic shock. However, its combination with hydrocortisone remains a common therapeutic approach in managing this critical condition.\",77\n201,HYDROCORTISONE,TRIAL,The trial involved administering hydrocortisone to one group of patients,61\n109,PLACEBO,HYDROCORTISONE,Hydrocortisone and placebo were the two treatments compared in the trial,52\n196,HYDROCORTISONE,SEVERE SEPSIS,Hydrocortisone was tested to see if it could prevent the development of septic shock in patients with severe sepsis,38\n108,PLACEBO,DELERIUM,Placebo was used as a control to compare the effects of hydrocortisone on delirium,35\n195,HYDROCORTISONE,CORTICUS STUDY,The CORTICUS study primarily evaluated the use of hydrocortisone as a treatment. The study found that hydrocortisone was effective in reversing septic shock more quickly.,33\n192,HYDROCORTISONE,NOREPINEPHRINE,Hydrocortisone was administered to patients who received norepinephrine,31\n205,HYDROCORTISONE,APROCCHSS,The APROCCHSS trial tested the efficacy of hydrocortisone in treating septic shock,31\n206,HYDROCORTISONE,INTENSIVE CARE UNIT (ICU),Hydrocortisone treatment was associated with lower mortality at ICU discharge in the trial,31\n193,HYDROCORTISONE,SURVIVING SEPSIS CAMPAIGN,\"The Surviving Sepsis Campaign, which provides guidelines for the management of sepsis, includes hydrocortisone as a recommended treatment option. Specifically, the campaign suggests the use of hydrocortisone for patients experiencing refractory septic shock, highlighting its role in managing this severe condition.\",30\n207,HYDROCORTISONE,HOSPITAL,Hydrocortisone treatment was associated with lower mortality at hospital discharge in the trial,30\n190,HYDROCORTISONE,FLUDROCORTISONE,\"Hydrocortisone and fludrocortisone are pharmaceutical agents that have been used together in various therapeutic and clinical trial settings. They were trial agents compared against placebos and have been specifically utilized in the treatment of septic shock and adrenal insufficiency. Notably, their combination was employed in the APROCCHSS trial, which focused on their efficacy in treating septic shock. These agents are often used in replacement therapy to manage conditions like septic shock, highlighting their importance in critical care settings.\",28\n191,HYDROCORTISONE,DOPAMINE,Hydrocortisone was administered to patients who received dopamine,28\n197,HYDROCORTISONE,SEVERE SEPSIS OR SEPTIC SHOCK STUDY,Hydrocortisone was one of the treatments evaluated in the study,28\n198,HYDROCORTISONE,DELERIUM,\"Hydrocortisone is a treatment that has been studied to assess its impact on the development of delirium. Research indicates that hydrocortisone treatment is associated with a lower risk of developing delirium, suggesting its potential benefit in managing or preventing this condition.\",25\n200,HYDROCORTISONE,RCT,RCTs are conducted to evaluate the effectiveness of hydrocortisone in treating septic shock,24\n208,HYDROCORTISONE,DROTRECOGIN ALFA,Hydrocortisone was tested alongside drotrecogin alfa in the APROCCHSS trial,23\n194,HYDROCORTISONE,ANNANE,Annane's study showed that hydrocortisone improved survival and reversal of septic shock,22\n199,HYDROCORTISONE,CRITICAL ILLNESS–RELATED CORTICOSTEROID INSUFFICIENCY (CIRCI),Hydrocortisone was studied in patients with CIRCI to assess its effects on septic shock,22\n202,HYDROCORTISONE,ROTEXMEDICA,Rotexmedica prepared the hydrocortisone used in the study,22\n203,HYDROCORTISONE,KLOCKE VERPACKUNGS SERVICE,Klocke Verpackungs Service was responsible for coding and masking the hydrocortisone vials,22\n204,HYDROCORTISONE,SUPERINFECTION,The use of hydrocortisone was associated with an increased incidence of superinfection,22\n210,FLUDROCORTISONE,APROCCHSS,The APROCCHSS trial tested the efficacy of fludrocortisone in treating septic shock,17\n211,FLUDROCORTISONE,INTENSIVE CARE UNIT (ICU),Fludrocortisone treatment was associated with lower mortality at ICU discharge in the trial,17\n212,FLUDROCORTISONE,HOSPITAL,Fludrocortisone treatment was associated with lower mortality at hospital discharge in the trial,16\n209,FLUDROCORTISONE,ANNANE STUDY,Fludrocortisone was used in the Annane study to treat patients,11\n213,FLUDROCORTISONE,DROTRECOGIN ALFA,Fludrocortisone was tested alongside drotrecogin alfa in the APROCCHSS trial,9\n869,RICHMOND AGITATION-SEDATION SCALE,DELERIUM,The Richmond Agitation-Sedation Scale is used to assess delirium in ICU patients,6\n870,CONFUSION ASSESSMENT METHOD FOR THE ICU,DELERIUM,The Confusion Assessment Method for the ICU is used to diagnose delirium in critically ill patients,6\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "parameters": {"model": "gpt-4o", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 2000, "n": 1}, "history": null}